Policy paper nuclear cardiology - Update 2018: Current status of clinical practice;Positionspapier Nuklearkardiologie - Update 2018: Aktueller Stand der klinischen Anwendung

NuklearMedizin

Volumn 57, Issue 4, 2018, Pages 146-152

  Lindner, Oliver ^a   Bauersachs, Johann ^b   Bengel, Frank M ^b   Burchert, Wolfgang ^a   Vom Dahl, Jürgen ^c   Dörr, Rolf ^d   Hacker, Marcus ^e   Kelm, Malte ^f   Rassaf, Tienush ^g   Rischpler, Christoph ^g   Schäfer, Wolfgang ^c   Schäfers, Michael A ^h   Silber, Sigmund ⁱ   Zimmermann, Rainer ^j  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KLINIKEN MARIA HILF GMBH   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ Kardiologische G   (Germany)

^j Klinikum Pforzheim GmbH   (Germany)

more..

Author keywords

indications; nuclear cardiology; PE T; Position paper; SPEC T

Indexed keywords

ARTICLE; BACTERIAL ENDOCARDITIS; CARDIAC SARCOIDOSIS; CARDIOLOGY; CARDIOMYOPATHY; CLINICAL PRACTICE; HEART AMYLOIDOSIS; AMYLOIDOSIS; CARDIAC IMAGING; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; ENDOCARDITIS; HEALTH CARE POLICY; HUMAN; NUCLEAR MEDICINE; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; SARCOIDOSIS; SCINTISCANNING;

AMYLOIDOSIS; CARDIAC IMAGING TECHNIQUES; CARDIOLOGY; CARDIOMYOPATHIES; CORONARY ARTERY DISEASE; ENDOCARDITIS; HEALTH POLICY; HUMANS; NUCLEAR MEDICINE; PRACTICE GUIDELINES AS TOPIC; RADIONUCLIDE IMAGING; SARCOIDOSIS;

EID: 85058688141     PISSN: 00295566     EISSN: 25676407     Source Type: Journal    
DOI: 10.3413/2018-06-0001     Document Type: Article

References (45)

1. Agostini D. Marie PY. Ben-Haim S. et al. Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging: 2016; 43 2423 2432.
2. Axer A. Hermann S. Harnessing the Maltodextrin Transport Mechanism for Targeted Bacterial Imaging: Structural Requirements for Improved in vivo Stability in Tracer Design. ChemMedChem: 2018; 13 241 250.
3. Bax JJ. Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol: 2015; 22 229 245.
4. Benz DC. Templin C. Kaufmann PA. et al. Ultralow-dose hybrid single photon emission computed tomography and coronary computed tomography angiography: a comprehensive and non-invasive diagnostic workup of suspected coronary artery disease. Eur Heart J: 2015; 36 3345.
5. Bundesamt für Strahlenschutz. Bekanntmachung der aktualisierten diagnostischen Referenzwerte für nuklearmedizinische Untersuchungen Vom 25 September 2012. Veröffentlicht am Freitag 19 Oktober 2012 BAnz AT 19.10.2012 B5.
6. Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale Versorgungs-Leitlinie Chronische KHK (Langfassung) 4. Auflage: 2016; AWMF-Register-Nr.: nvl-004. Kurzfassung: Albus C. Barkhausen J. Fleck E. Haasenritter J. Lindner O. Silber S. für die Leitliniengruppe NVL Chronische KHK Diagnostik der chronischen koronaren Herzkrankheit Klinische Leitlinie. Deutsches Ärzteblatt: 2017; 114 712 719.
7. Caforio AL. Pankuweit S. Arbustini E. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J: 2013; 34 2636 2648 2648a-2648d.
8. Caobelli F. Wollenweber T. Bavendiek U. et al. Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis. Eur Heart J: 2017; 38 436 443.
9. Chareonthaitawee P. Beanlands RS. Chen W. et al. Joint SNMMI-ASNC Expert Consensus Document on the Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med: 2017; 58 1341 1353.
10. Dörr R. Ischemia Studie - Rationale, Design und bisheriger Randomisierungsstatus. Nuklearmediziner: 2017; 40 48 53.
11. Einstein AJ. Blankstein R. Andrews H. et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: the MILLISIEVERT study. J Nucl Med: 2014; 55 1430 1437.
12. Erba PA. Conti U. Lazzeri E. et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med: 2012; 53 1235 1243.
13. Falk RH. Alexander KM. Liao R. et al. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol: 2016; 68 1323 1341.
14. Frantz S. Buerke M. Horstkotte D. et al. Kommentar zu den 2015 - Leitlinien der Europäischen Gesellschaft für Kardiologie zur Infektiösen Endokarditits. Kardiologe: 2016; 10 142 148.
15. Gomes A. Glaudemans A. Touw DJ. et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis: 2017; 17 e1 e14.
16. Gould KL. Johnson NP. Bateman TM. et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decisionmaking. J Am Coll Cardiol: 2013; 62 1639 1653.
17. Greenwood JP. Ripley DP. Berry C. et al. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. JAMA: 2016; 316 1051 1060.
18. Gulati V. Ching G. Heller GV. The role of radionuclide imaging in heart failure. J Nucl Cardiol: 2013; 20 1173 1183.
19. Habib G. Lancellotti P. Antunes MJ. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J: 2015; 36 3075 3128.
20. Hachamovitch R. Hayes SW. Friedman JD. et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation: 2003; 107 2900 2907.
21. Hsu B. Chen FC. Wu TC. et al. Quantitation of myocardial blood flow and myocardial flow reserve with 99mTc-sestamibi dynamic SPECT/CT to enhance detection of coronary artery disease. European journal of nuclear medicine and molecular imaging: 2014; 41 2294 2306.
22. Hyafil F. Rouzet F. Lepage L. et al. Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. Eur Heart J Cardiovasc Imaging: 2013; 14 586 594.
23. Juneau D. Golfam M. Hazra S. et al. Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging: 2017; 10 e005772.
24. Kajander S. Joutsiniemi E. Saraste M. et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation: 2010; 122 603 613.
25. Knuuti J. Bengel F. Bax JJ. et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. Eur Heart J: 2014; 35 633 638.
26. Liga R. Vontobel J. Rovai D. et al. Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging: 2016; 17 951 960.
27. Lindner O. Bengel F. Burchert W. et al. Myokard-Perfusions-SPECT (DGN Handlungsempfehlung (S1-Leitlinie)). 2017;AWMF Registernummer 031-006. www.awmf.org
28. Lindner O. Burchert W. Schäfer W. et al. Myocardial perfusion SPECT 2015 in Germany. Results of the 7th survey. Nuklearmedizin: 2017; 56 31 38.
29. Marques KM. Knaapen P. Boellaard R. et al. Microvascular function in viable myocardium after chronic infarction does not influence fractional flow reserve measurements. J Nucl Med: 2007; 48 1987 1992.
30. McMurray JJ. Adamopoulos S. Anker SD. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail: 2012; 14 803 869.
31. Montalescot G. Sechtem U. Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J: 2013; 34 2949 3003.
32. O'Meara E. Mielniczuk LM. Wells GA. et al. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials: 2013; 14 218.
33. Packard RR. Huang SC. Dahlbom M. et al. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med: 2014; 55 1438 1444.
34. Pettersson GB. Coselli JS. Pettersson GB. et al.: 2016;The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary. J Thorac Cardiovasc Surg: 2017; 153 1241 1258 e1229.
35. Rouzet F. Chequer R. Benali K. et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med: 2014; 55 1980 1985.
36. Schaap J. De Groot JA. Nieman K. et al. Added value of hybrid myocardial perfusion SPECT and CT coronary angiography in the diagnosis of coronary artery disease. Eur Heart J Cardiovasc Imaging: 2014; 15 1281 1288.
37. Schäfers M. Bengel F. Bull U. et al. Position paper nuclear cardiology: update 2008. Nuklearmedizin: 2009; 48 71 78.
38. Schinkel AF. Bax JJ. Poldermans D. et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol: 2007; 32 375 410.
39. Slart R. Glaudemans A. Lancellotti P. et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol: 2018; 25 298 319.
40. Sohns JM. Bavendiek U. Ross TL. et al. Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging. Circ Cardiovasc Imaging: 2017; 10 e005376.
41. Soman P. Lahiri A. Mieres JH. et al. Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging. J Nucl Cardiol: 2009; 16 82 91.
42. Verberne HJ. Acampa W. Anagnostopoulos C. et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging: 2015; 42 1929 1940.
43. Vrachimis A. Honold L. Faust A. et al. New molecular probes of vascular inflammation. Q J Nucl Med Mol Imaging: 2016; 60 194 204.
44. Windecker S. Kolh P. Alfonso F. et al. 2014 ESC/ EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J: 2014; 35 2541 2619.
45. Wollenweber T. Bengel FM. Cardiac molecular imaging. Semin Nucl Med: 2014; 44 386 397.